Search

Type

Audience

Category

Issue

Last updated

Recall class

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.

Displaying 1 - 15 of 717 items.

" " RUZURGI (amifampridine) - Authorization Status
UPDATED INFORMATION – January 20, 2023 On January 10, 2023, following a Federal Court of Appeal decision, the June 24, 2021 decision of the Minister of Health on the application of the data protection provisions was restored, and a new Notice of…
AlertHealth professional risk communication | 2023-01-20
" " Belzer MPS and Belzer UW: Particulate matter
Presence of particulate matter in affected lot.
RecallHealth product recall | 2023-01-18
" " EVUSHELD (tixagevimab and cilgavimab for injection) - Risk of Prophylaxis or Treatment Failure due to Antiviral Resistance to specific SARS-CoV-2 Subvariants
UPDATED INFORMATION – 2023/01/17 Neutralization data for the following SARS-CoV-2 Omicron subvariants have been added to the Canadian Product Monograph: Omicron BA.2.75.2, BF.7, BJ.1, BN.1, BQ.1, BQ.1.1, and XBB. See Table 1 (below) for a summary…
AlertHealth professional risk communication | 2023-01-17
" " Flourimax suspension: Out of specification
The concentration of the medicinal ingredient, sodium fluoride, is out of specification in the affected lot.
RecallHealth product recall | 2022-12-15
" " Allergenic extract non pollens (Peanut allergy): False negative for skin test
Affected lot may result in a false negative for skin test (peanut allergy).
RecallHealth product recall | 2022-12-14
" " 18F-Fludeoxyglucose (18F-FDG); Sterility concerns
Product sterility may be compromised in the affected lot.
RecallHealth product recall | 2022-12-14
" " COMIRNATY Original & Omicron BA.4/BA.5 Bivalent Vaccine with English-only Vial and Carton Labels: New Formulation for Use in Children 5 to Less Than 12 Years of Age
On December 9, 2022, Health Canada authorized a new formulation of the bivalent vaccine, COMIRNATY Original & Omicron BA.4/BA.5, as a booster dose for active immunization against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory…
AlertHealth professional risk communication | 2022-12-09
" " Now Kids Vitamin D-3: Out of Specification
Affected lot contains active ingredient (Cholecalciferol) levels outside of the labelled claim.
RecallHealth product recall | 2022-12-08
" " NAT-Bendamustine: Discoloration
The colour is out of specification in the affected lot(s).
RecallHealth product recall | 2022-12-06
" " OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)
OCALIVA received a Notice of Compliance with Conditions in May 2017 for the treatment of PBC, pending the results of trials to verify its clinical benefit. OCALIVA is now contraindicated for PBC patients with advanced disease, such as those with Child…
AlertHealth professional risk communication | 2022-12-05
" " Tums Peppermint Regular Strength Tablets: Foreign matter
Affected lots may contain the presence of foreign matter.
RecallHealth product recall | 2022-12-05
" " Privigen: Series of adverse reactions
Affected lot being voluntarily recalled due to a series of adverse reactions.
RecallHealth product recall | 2022-12-01
" " SPIKEVAX Bivalent (Original / Omicron BA.4/5) (elasomeran/davesomeran) COVID-19 Vaccine with English-only Vial and Carton Labels
Health Canada authorized SPIKEVAX Bivalent (Original / Omicron BA.4/5) (elasomeran/davesomeran) on November 3, 2022. In order to provide rapid access to the vaccine, Moderna will distribute product vials and cartons labelled in English only with the…
AlertHealth professional risk communication | 2022-11-18
" " Allergenic extract non pollens (Peanut allergy): False negative for skin test
Affected lot may result in a false negative for skin test (peanut allergy)
RecallHealth product recall | 2022-11-15
" " Baxter Corporation; leaks of intravenous bags
Intravenous bag may be leaking in affected lots.
RecallHealth product recall | 2022-11-03
Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.